Physicochemical compatibility between ketoprofen lysine salt injections (Artrosilene®) and pharmaceutical products frequently used for combined therapy by intravenous administration

2003 ◽  
Vol 32 (6) ◽  
pp. 1235-1241 ◽  
Author(s):  
Roberto Anacardio ◽  
Orietta Perilli ◽  
Sandro Bartolini ◽  
Marco M. Gentile ◽  
Pietro Mazzeo ◽  
...  
Keyword(s):  
Intravenous Administration ◽  
Combined Therapy ◽  
Pharmaceutical Products ◽  
Ketoprofen Lysine Salt

scholarly journals HPLC Investigated Physicochemical Compatibility between Artrosilene® Injectable Solution and other Pharmaceutical Products Frequently Used for Combined Therapy into Elastomeric Baxter LV5 Infusion Devices

2005 ◽  
Vol 18 (4) ◽  
pp. 791-798 ◽  
Author(s):  
R. Anacardio ◽  
S. Bartolini ◽  
M.M. Gentile ◽  
M. Bagnasco ◽  
G. Carlucci
Keyword(s):  
Combined Therapy ◽  
Reversed Phase ◽  
Pharmaceutical Products ◽  
Hplc Method ◽  
Tramadol Hydrochloride ◽  
Mixing Ratios ◽  
Before And After ◽  
Infusion Systems ◽  
Infusion Devices ◽  
Ketoprofen Lysine Salt

Ketoprofen lysine salt (Artrosilene®, injectable solution) is a non-steroidal anti-inflammatory agent frequently administered by slow intravenous infusion with portable elastomeric infusion systems in association regimen with other analgesic drugs. The aim of this study was to investigate the physicochemical compatibility between ketoprofen lysine salt (Artrosilene®, injectable solution) and other injectable drugs frequently used in association, such as tramadol hydrochloride, keterolac tromethamine and morphine hydrochloride, into the Infusor LV5, Baxter elastomeric infusion system. Physicochemical properties of drug mixture, including colour, clarity, pH and drug content were observed or measured by a reversed-phase HPLC method with UV detection, before and after (up to 7 days) mixing at room temperature and under light protection. The results obtained demonstrated the physicochemical compatibility of ketoprofen lysine salt (Artrosilene®, injectable solution) with all drug formulations at every tested mixing ratios into Baxer Infusor LV5 infusion devices.

Physicochemical compatibility between thiocolchicoside injections (Miotens®) and pharmaceutical products frequently used for combined therapy

Il Farmaco ◽  
2002 ◽  
Vol 57 (11) ◽  
pp. 925-930 ◽  
Author(s):  
Roberto Anacardio ◽  
Orietta Perilli ◽  
Federica Pagnanelli ◽  
Sandro Bartolini ◽  
Marco M. Gentile ◽  
...  
Keyword(s):  
Combined Therapy ◽  
Pharmaceutical Products

1869: Combined Therapy of FR167653 and Cyclosporin A Significantly Prolonged Animal Survival in ratRenal Allografts

2004 ◽  
Vol 171 (4S) ◽  
pp. 493-494
Author(s):  
Haruhito Azuma ◽  
Shiro Takahara ◽  
Takashi Wada ◽  
Takeshi Sakamoto ◽  
Akihiko Okuyama ◽  
...  
Keyword(s):  
Cyclosporin A ◽  
Combined Therapy ◽  
Animal Survival

Intravenous administration of furosemide in heart failure

JAMA ◽  
1967 ◽  
Vol 200 (10) ◽  
pp. 824-829 ◽  
Author(s):  
M. Davidov
Keyword(s):  
Heart Failure ◽  
Intravenous Administration

Combined Therapy Calms Panic Patients

2006 ◽  
Vol 34 (1) ◽  
pp. 31
Author(s):  
Heidi Splete
Keyword(s):  
Combined Therapy
Sign in / Sign up

Export Citation Format

Share Document